What is Actinium Pharmaceuticals, Inc's Market Cap?

Actinium Pharmaceuticals, Inc's Market Cap is $39.6M, based on as-reported figures from SEC (XBRL) filings.

What is Actinium Pharmaceuticals, Inc's Enterprise Value?

Actinium Pharmaceuticals, Inc's Enterprise Value is -$2.5M, based on as-reported figures from SEC (XBRL) filings.

What is Actinium Pharmaceuticals, Inc's Price / Sales?

Actinium Pharmaceuticals, Inc's Price / Sales is 440.2×, based on as-reported figures from SEC (XBRL) filings.

What is Actinium Pharmaceuticals, Inc's EV / Revenue?

Actinium Pharmaceuticals, Inc's EV / Revenue is n/m, based on as-reported figures from SEC (XBRL) filings.

What is Actinium Pharmaceuticals, Inc's EV / EBITDA?

Actinium Pharmaceuticals, Inc's EV / EBITDA is 0.1×, based on as-reported figures from SEC (XBRL) filings.

What is Actinium Pharmaceuticals, Inc's Revenue (TTM)?

Actinium Pharmaceuticals, Inc's Revenue (TTM) is $90.0K, based on as-reported figures from SEC (XBRL) filings.

What is Actinium Pharmaceuticals, Inc's Net Income (TTM)?

Actinium Pharmaceuticals, Inc's Net Income (TTM) is -$23.5M, based on as-reported figures from SEC (XBRL) filings.

What is Actinium Pharmaceuticals, Inc's EBITDA?

Actinium Pharmaceuticals, Inc's EBITDA is -$25.4M, based on as-reported figures from SEC (XBRL) filings.

What is Actinium Pharmaceuticals, Inc's Diluted EPS (TTM)?

Actinium Pharmaceuticals, Inc's Diluted EPS (TTM) is -0.75, based on as-reported figures from SEC (XBRL) filings.

What is Actinium Pharmaceuticals, Inc's EBITDA Margin?

Actinium Pharmaceuticals, Inc's EBITDA Margin is -28174.4%, based on as-reported figures from SEC (XBRL) filings.

Actinium Pharmaceuticals, Inc (ATNM) Financial Statements

Actinium Pharmaceuticals, Inc

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG001SV3L17

XASE · usd

1.26▲ 0.03 (2.44%)

As of 2026-09-09

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales

EV / Revenue

EV / EBITDA

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin

Net Debt

Trading Information

Previous Close1.23

Day's Range1.06 – 1.25

52-Week Range0.74 – 1.74

Volume568.4K

Avg Volume160.4K

Share Statistics

Shares Outstanding

Employees25

ExchangeXASE

Listed2007-07-19

Share count as of August 6, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Actinium Pharmaceuticals, Inc (ATNM)

What is Actinium Pharmaceuticals, Inc's Market Cap?: Actinium Pharmaceuticals, Inc's Market Cap is $39.6M, based on as-reported figures from SEC (XBRL) filings.
What is Actinium Pharmaceuticals, Inc's Enterprise Value?: Actinium Pharmaceuticals, Inc's Enterprise Value is -$2.5M, based on as-reported figures from SEC (XBRL) filings.
What is Actinium Pharmaceuticals, Inc's Price / Sales?: Actinium Pharmaceuticals, Inc's Price / Sales is 440.2×, based on as-reported figures from SEC (XBRL) filings.
What is Actinium Pharmaceuticals, Inc's EV / Revenue?: Actinium Pharmaceuticals, Inc's EV / Revenue is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Actinium Pharmaceuticals, Inc's EV / EBITDA?: Actinium Pharmaceuticals, Inc's EV / EBITDA is 0.1×, based on as-reported figures from SEC (XBRL) filings.
What is Actinium Pharmaceuticals, Inc's Revenue (TTM)?: Actinium Pharmaceuticals, Inc's Revenue (TTM) is $90.0K, based on as-reported figures from SEC (XBRL) filings.
What is Actinium Pharmaceuticals, Inc's Net Income (TTM)?: Actinium Pharmaceuticals, Inc's Net Income (TTM) is -$23.5M, based on as-reported figures from SEC (XBRL) filings.
What is Actinium Pharmaceuticals, Inc's EBITDA?: Actinium Pharmaceuticals, Inc's EBITDA is -$25.4M, based on as-reported figures from SEC (XBRL) filings.
What is Actinium Pharmaceuticals, Inc's Diluted EPS (TTM)?: Actinium Pharmaceuticals, Inc's Diluted EPS (TTM) is -0.75, based on as-reported figures from SEC (XBRL) filings.
What is Actinium Pharmaceuticals, Inc's EBITDA Margin?: Actinium Pharmaceuticals, Inc's EBITDA Margin is -28174.4%, based on as-reported figures from SEC (XBRL) filings.